Skip to main content

New Human Tumor Biomarker Performance Luminex Panel

Prepare to revolutionize your cancer research with our new Human Tumor Biomarker Luminex Panel, set to launch soon. This panel, compromised of 28 tumor biomarkers, provides an abundance of data for many cancer types, such as prostate, colorectal, and lung cancer. Sign up below to be the first to know when this panel is available or if interested in our exclusive beta testing program.

  • Customizable tumor panel of up to 28 tumor biomarkers with only 50 uL of sample
  • Validated for use with serum, plasma (including Streck plasma), cell culture supernates, cell lysates, and tissue lysates
  • Get results quickly with 3.5-hour assay time

Analytes Available:

AFP

CA15-3

CA125

CA19-9

CD40 Ligand/TNFSF5

CEACAM-5

CG beta (HCG beta)

Chromogranin A (CHGA)

CYFRA21-1

Fas

Fas Ligand

FGF basic

Glypican-1

HGF

HE4/WFDC2

IL-6

IL-8/CXCL8

Leptin

MIF

Neuron-specific enolase (NSE)

Osteopontin/OPN

PSA Total

Prolactin

SCF/c-kit Ligand

TGF-alpha

Thyroglobulin

TNF-alpha

VEGF

Cancer Sample Data:

Prostate and colorectal cancer serum samples were tested alongside healthy controls on the Human Tumor Biomarker Panel and significant differences were observed over many analytes.  A selection of these are shown below.

Healthy Controls vs Prostate Cancer Serum Samples
Healthy Controls vs Colorectal Cancer Serum Samples

Learn More or Sign Up for Beta Testing Program

Luminex® is a Registered Trademark of Luminex Corporation.